MacroGenics | MGNX - Current Assets


MacroGenics reported $219.94M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
AbbVie USD 29.06B 523M Dec/2025
Amgen USD 29.06B 1.17B Dec/2025
AstraZeneca USD 28.72B 1.22B Dec/2025
Biogen USD 8.97B 37.5M Dec/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Daiichi Sankyo JPY 2.1T 218.5B Dec/2025
Eli Lilly USD 55.63B 6.44B Dec/2025
Genmab DKK 2.88B 1.59B Dec/2025
Geron USD 520.27M 2.07M Dec/2025
Gilead Sciences USD 19.89B 1.05B Dec/2025
J&J USD 55.62B 1.01B Dec/2025
Karyopharm Therapeutics USD 103.15M 13.4M Dec/2025
MacroGenics USD 219.94M 12.15M Dec/2025
Merck USD 47.56B 10.49B Sep/2025
Pfizer USD 46.92B 3.22B Sep/2025
Puma Biotechnology USD 143.58M 7M Sep/2025
Regeneron Pharmaceuticals USD 18.02B 41.2M Dec/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Xencor USD 599.82M 81.38M Dec/2025